Back to Capital International Investors Capital International Investors

RAPPRAPP
Showing 8 of 9 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in RAPPORT THERAPEUTICS INC

Capital International Investors holds 2.9M shares of RAPP (RAPPORT THERAPEUTICS INC), worth $121.8M as of 2026-Q2. The position was decreased (-5.7% shares). RAPP represents 0.0% of Capital International Investors's portfolio.

Current Value

$121.8M

Current Shares

2.9M

Total Value Change

+$68.5M

Total Shares Change

+319,429

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.9M
-5.7%
$121.8M0.0%$41.67
0
2026-Q1
Decreased
3.1M
-8.9%
$96.9M0.0%$27.85
0
2025-Q4
Unchanged
3.4M
0.0%
$103.2M0.0%$30.64
0
2025-Q3
Increased
3.4M
+30.7%
$101.1M0.0%$27.97
38
2025-Q2
Unchanged
2.6M
0.0%
$29.6M0.0%$11.43
0
2025-Q1
Unchanged
2.6M
0.0%
$26.1M0.0%$10.05
0
2024-Q4
Unchanged
2.6M
0.0%
$46.2M0.0%$18.49
0
2024-Q3
Decreased
2.6M
0.0%
$53.3M0.0%$21.33
0

Other major holders of RAPP: FMR LLC, GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used